Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Incidence of Cytomegalovirus (CMV) Reactivation after Autologous Peripheral Blood Stem Cell Transplantation (ASCT) in 324 Patients with Multiple Myeloma and Lymphoma: A Single-Center Study at the American University of Beirut Medical Center (AUBMC)

Radwan Massoud, MD, Rita Assi, MD, Elie Fares, Nabila Kreidieh, Rami Mahfouz, Souha Kanj, Aline El-Zakhem, Mohamed A. Kharfan-Dabaja, MD, Ali Bazarbachi, MD PhD, Jean El Cheikh, MD PhD

Blood (2016) 128 (22): 5824.

https://doi.org/10.1182/blood.V128.22.5824.5824

Published: 2016

Journal Articles

Azacitidine As Post-Allograft Maintenance Helps Reduce Relapse Risk in High-Risk MDS and AML

Jean El Cheikh, MD PhD, Radwan Massoud, Elie Fares, Nabila Kreidieh, Rami Mahfouz, Mohamed A Kharfan-Dabaja, MD, Ali Bazarbachi, MD PhD

Blood (2016) 128 (22): 5872.

https://doi.org/10.1182/blood.V128.22.5872.5872

Published: 2016

Journal Articles

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Sabine Fürst, MD, Jean El Cheikh, MD PhD, Bénédicte Devictor, MD, Sandra Cournier, Angela Granata, MD, Samia Harbi, MD, Raynier Devillier, MD PhD, Faezeh Legrand, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Jean Pierre Weiller, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Borje S. Andersson, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 5751.

https://doi.org/10.1182/blood.V128.22.5751.5751

Published: 2016

Journal Articles

Post Transplant Brentuximab Maintenance Appears More Effective Than Post Transplant Salvage Brentuximab for Relapsed/Refractory Hogkin's Lymphoma

Amanda Chidiac, Radwan Massoud, MD, Mohamad Haidar, Elie Fares, Ali Bazarbachi, MD PhD, Jean El Cheikh, MD PhD

Blood (2016) 128 (22): 5357.

https://doi.org/10.1182/blood.V128.22.5357.5357

Published: 2016

Journal Articles

Dynamics of Molecular Response in AML Patients with NPM1 and FLT3 Mutations Undergoing Allogeneic Stem Cell Transplant

Rana Salem, MD, Radwan Massoud, MD, Rami Mahfouz, Ali Bazarbachi, MD PhD, Jean El Cheikh, MD PhD

Blood (2016) 128 (22): 5238.

https://doi.org/10.1182/blood.V128.22.5238.5238

Published: 2016

Journal Articles

Efficacy and Feasibility of Sorafenib As a Maintenance Agent after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia

Blood (2016) 128 (22): 4624.

https://doi.org/10.1182/blood.V128.22.4624.4624

Published: 2016

Journal Articles

Successfull Engraftment and Clearance of Donor Specific Antibodies after Haploidentical Related Stem Cell Transplantation for an Adult Patient with Sickle Cell Disease

Sabine FÜrst, MD, Emmanuelle Bernit, MD, Jean El Cheikh, MD, Angela Granata, MD, Samia Harbi, MD, Bilal Mohty, MD, Laurence Caymaris, Head Nurse, Claude Lemarie, MD, Boris Calmels, PharmD, PhD, Christian Chabannon, MD PhD, Christophe Picard, Djamel Mokart, MD PhD, Borje Andersson, MD PhD, Didier Blaise, MD

Blood (2014) 124 (21): 5792.

https://doi.org/10.1182/blood.V124.21.5792.5792

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Following Reduced-Intensity Conditioning Regimen for Elderly Patients (60 years and older) with Hematological Malignancies Using Unrelated Donors: A Retrospective Study on Behalf of the French Society for Stem Cell Transplantation and Cell Therapies (SFGM-TC)

Jean El Cheikh, MD, Patrick Sfumato, PhD, Nathalie Fegueux, MD, Mohamad Mohty, MD PhD, Ibrahim Yakoub-Agha, MDPhD, Stephane Vigouroux, MD, Yves Beguin, MD PhD, Gerard Socie, MD PhD, Jerome Cornillon, Sylvain Thepot, MD, Jacques-Olivier Bay, MD PhD, Mauricette Michallet, MD PhD, Regis Peffault de Latour, MD PhD

Blood (2014) 124 (21): 2472.

https://doi.org/10.1182/blood.V124.21.2472.2472

Published: 2014

Journal Articles

Feasibility and Efficacy of Tandem Autologous-Allogeneic Transplantation in a Cohort of 111 Patients Affected By High-Risk Hodgkin's and Non-Hodgkin's Lymphoma

Roberto Crocchiolo, MD PhD, Luca Castagna, MD, Sabine Fuerst, MD, Jean El Cheikh, MD, Barbara Sarina, MD, Stefania Bramanti, Angela Granata, MD, Lucio Morabito, MD, Laura Giordano, MD, Sylvain Garciaz, MD, Diane Coso, MD, Reda Bouabdallah, MD, Monica Balzarotti, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Didier Blaise, MD PhD

Blood (2014) 124 (21): 3863.

https://doi.org/10.1182/blood.V124.21.3863.3863

Published: 2014

Journal Articles

Tacrolimus (FK) Compared to Cyclosporine a (CyA) after Haploidentical T Cell Replete Stem Cell Transplantation (Haplo-SCT) with Post-Infusion Cyclophosphamide: A Retrospective Analysis

Luca Castagna, Stefania Bramanti, MD, Sabine Furst, Barbara Sarina, MD, Roberto Crocchiolo, MD PhD, Laura Giordano, MD, Jean El Cheikh, MD, Angela Granata, MD, Lucio Morabito, MD, Elisa Mauro, MD, Catherine Faucher, Bilal Mothy, Samia Harbi, MD, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Didier Blaise, MD

Blood (2014) 124 (21): 3902.

https://doi.org/10.1182/blood.V124.21.3902.3902

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation From Haploidentical Donor After Reduced Intensity Conditioning Regimen Allows Promising Disease Control In Patients With Hematological Diseases

Raynier Devillier, MD, Luca Castagna, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Samia Harbi, Jean El Cheikh, MD, Angela Granata, Bilal Mohty, MD, Catherine Faucher, MD, Didier Blaise, MD

Blood (2013) 122 (21): 2139.

https://doi.org/10.1182/blood.V122.21.2139.2139

Published: 2013

Journal Articles

Lower Relapse and Better PFS Among Chemosensitive Patients Undergoing Allogeneic Transplantation By Haploidentical Compared With HLA-Identical DONOR: Results On A Cohort Of 94 Patients With Hodgkin’S Lymphoma

Luca Castagna, MD, Roberto Crocchiolo, MD, PhD, Stefania Bramanti, MD, Sabine Furst, MD, Barbara Sarina, MD, Jean El Cheikh, MD, Angela Granata, Raynier Devillier, MD, Sylvain Garciaz, MD, Reda Bouabdallah, MD, Armando Santoro, MD, Didier Blaise

Blood (2013) 122 (21): 2144.

https://doi.org/10.1182/blood.V122.21.2144.2144

Published: 2013

Journal Articles

Role Of Allogeneic Transplant In Poor Risk CLL Patients: A Long-Term Monocentric Experience In 39 Patients

Therese Aurran-Schleinitz, MD, Anne Wanquet, Sabine Furst, MD, Benjamin Esterni, Ph.D., Reda Bouabdallah, MD, Diane Coso, MD, Christine Arnoulet, Pharm. D., Jean El Cheikh, MD, Catherine Faucher, MD, Luca Castagna, MD, Christian Chabannon, MD, PhD, Didier Blaise

Blood (2013) 122 (21): 5531.

https://doi.org/10.1182/blood.V122.21.5531.5531

Published: 2013

Journal Articles

Reduced Intensity Conditioning Based On Fludarabine, Intravenous Busulfan (2 Days) and Antithymocyte Globulins (2 Days) Results In High Disease Free Survival Without Persisting Gvhd In Patients Transplanted For Hematological Malignancies: Large Single Center Cohort With Long Follow-Up

Raynier Devillier, MD, Sabine Furst, MD, Roberto Crocchiolo, MD PhD, Samia Harbi, Luca Castagna, Jean El Cheikh, MD, Angela Granata, Catherine Faucher, MD, Anne Marie Stoppa, Bilal Mohty, MD, Thomas Prebet, MD, PhD, Diane Coso, MD, Jerome Rey, MD, Reda Bouabdallah, MD, Norbert Vey, MD, Didier Blaise, MD

Blood (2013) 122 (21): 3364.

https://doi.org/10.1182/blood.V122.21.3364.3364

Published: 2013

Journal Articles

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

Roberto Crocchiolo, MD PhD, Sabine Fuerst, MD, Jean El-Cheikh, MD PhD, Angela Granata, Claire Oudin, Geoffroy Venton, Norbert Vey, Reda Bouabdallah, MD, Anne Marie Stoppa, Florence Broussais, MD, Aude Charbonnier, MD, PhD, Claude Lemarie, Diane Coso, MD, Thomas Prebet, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3029.

https://doi.org/10.1182/blood.V120.21.3029.3029

Published: 2012

Journal Articles

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

Sabine Furst, MD, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Claire Oudin, Angela Granata, Geoffroy Venton, Claude Lemarie, Diane Coso, MD, Reda Bouabdallah, MD, Anne Marie Stoppa, Norbert Vey, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3031.

https://doi.org/10.1182/blood.V120.21.3031.3031

Published: 2012

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in First Line High Risk Multiple Myeloma Patients: Evolving Strategies with the Immunomodulating Drugs.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Jean El-Cheikh, MD PhD, Stéphane Morisset, Stat., Anne Sirvent, MD, Oumedaly Reman, MD, Jérôme Cornillon, MD, Reza Tabrizi, MD, Noel Milpied, MD, Jean-Luc Harousseau, MD, Hélène Labussière-Wallet, MD, Franck E. Nicolini, MD, PhD, Charles Dumontet, M. D., Ph.D., Mohamad Mohty, Michel Attal, MD, Didier Blaise, MD, Philippe Moreau, MD, Hervé Avet-Loiseau, MD, PhD

Blood (2012) 120 (21): 3116.

https://doi.org/10.1182/blood.V120.21.3116.3116

Published: 2012

Journal Articles

NK Cells Display Poor Anti Lymphoma and AML Function At Early Times Following Allogenic HLA-Identical SCT for Leukemia and Lymphomas.

Daniel Olive, MD, PhD, Caroline Pical, Jean El-Cheikh, MD PhD, Roberto Crocchiolo, MD, Sabine Furst, MD, Didier Blaise, MD, Cyril Fauriat

Blood (2012) 120 (21): 3045.

https://doi.org/10.1182/blood.V120.21.3045.3045

Published: 2012

Journal Articles

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus On Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Jean El-Cheikh, MD PhD, Raynier Devillier, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Boris Calmels, Catherine Faucher, Anne Marie Stoppa, MD, Angela Granata, Claire Oudin, Patrick Ladaique, Claude Lemarie, Geoffroy Venton, Reda Bouabdallah, MD, Christine Zandotti, Pierre Berger, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4496.

https://doi.org/10.1182/blood.V120.21.4496.4496

Published: 2012

Journal Articles

Efficacy and Safety of Micafungin for Prophylaxis of Invasive Fungal Infections in Patients Undergoing Haplo-Identical Hematopoietic Stem Cell Transplant

Jean El-Cheikh, MD PhD, Geoffroy Venton, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Catherine Faucher, Angela Granata, Claire Oudin, Reda Bouabdallah, MD, Norbert Vey, MD, Segolene Duran, Pierre Berger, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4505.

https://doi.org/10.1182/blood.V120.21.4505.4505

Published: 2012

NARROW

Incidence of Cytomegalovirus (CMV) Reactivation after Autologous Peripheral Blood Stem Cell Transplantation (ASCT) in 324 Patients with Multiple Myeloma and Lymphoma: A Single-Center Study at the American University of Beirut Medical Center (AUBMC)

Azacitidine As Post-Allograft Maintenance Helps Reduce Relapse Risk in High-Risk MDS and AML

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Post Transplant Brentuximab Maintenance Appears More Effective Than Post Transplant Salvage Brentuximab for Relapsed/Refractory Hogkin's Lymphoma

Dynamics of Molecular Response in AML Patients with NPM1 and FLT3 Mutations Undergoing Allogeneic Stem Cell Transplant

Efficacy and Feasibility of Sorafenib As a Maintenance Agent after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia

Successfull Engraftment and Clearance of Donor Specific Antibodies after Haploidentical Related Stem Cell Transplantation for an Adult Patient with Sickle Cell Disease

Feasibility and Efficacy of Tandem Autologous-Allogeneic Transplantation in a Cohort of 111 Patients Affected By High-Risk Hodgkin's and Non-Hodgkin's Lymphoma

Tacrolimus (FK) Compared to Cyclosporine a (CyA) after Haploidentical T Cell Replete Stem Cell Transplantation (Haplo-SCT) with Post-Infusion Cyclophosphamide: A Retrospective Analysis

Allogeneic Hematopoietic Stem Cell Transplantation From Haploidentical Donor After Reduced Intensity Conditioning Regimen Allows Promising Disease Control In Patients With Hematological Diseases

Lower Relapse and Better PFS Among Chemosensitive Patients Undergoing Allogeneic Transplantation By Haploidentical Compared With HLA-Identical DONOR: Results On A Cohort Of 94 Patients With Hodgkin’S Lymphoma

Role Of Allogeneic Transplant In Poor Risk CLL Patients: A Long-Term Monocentric Experience In 39 Patients

Reduced Intensity Conditioning Based On Fludarabine, Intravenous Busulfan (2 Days) and Antithymocyte Globulins (2 Days) Results In High Disease Free Survival Without Persisting Gvhd In Patients Transplanted For Hematological Malignancies: Large Single Center Cohort With Long Follow-Up

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

Allogeneic Hematopoietic Stem Cell Transplantation in First Line High Risk Multiple Myeloma Patients: Evolving Strategies with the Immunomodulating Drugs.

NK Cells Display Poor Anti Lymphoma and AML Function At Early Times Following Allogenic HLA-Identical SCT for Leukemia and Lymphomas.

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus On Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Efficacy and Safety of Micafungin for Prophylaxis of Invasive Fungal Infections in Patients Undergoing Haplo-Identical Hematopoietic Stem Cell Transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only